IRIS - Res&Arch Institutional Research Information System - Research & Archive

ORLACCHIO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.054
AS - Asia 4.337
EU - Europa 3.824
SA - Sud America 1.098
AF - Africa 93
Continente sconosciuto - Info sul continente non disponibili 37
OC - Oceania 3
Totale 14.446
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.921
SG - Singapore 1.883
IE - Irlanda 1.121
BR - Brasile 938
RU - Federazione Russa 810
VN - Vietnam 797
HK - Hong Kong 697
CN - Cina 564
IT - Italia 516
FI - Finlandia 329
DE - Germania 188
SE - Svezia 131
UA - Ucraina 123
FR - Francia 118
GB - Regno Unito 111
AT - Austria 108
PL - Polonia 76
CA - Canada 70
KR - Corea 63
AR - Argentina 61
IN - India 56
JP - Giappone 48
MX - Messico 43
ZA - Sudafrica 43
NL - Olanda 37
EU - Europa 36
BD - Bangladesh 32
RO - Romania 32
TR - Turchia 29
CH - Svizzera 28
EC - Ecuador 28
UZ - Uzbekistan 28
ID - Indonesia 22
IQ - Iraq 19
ES - Italia 18
CO - Colombia 17
BE - Belgio 16
MA - Marocco 16
PK - Pakistan 16
GR - Grecia 14
LB - Libano 14
CL - Cile 13
CZ - Repubblica Ceca 12
PE - Perù 12
PY - Paraguay 11
VE - Venezuela 11
EG - Egitto 9
JO - Giordania 9
LT - Lituania 8
AZ - Azerbaigian 7
MY - Malesia 7
SA - Arabia Saudita 7
DK - Danimarca 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
IL - Israele 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
HN - Honduras 4
JM - Giamaica 4
KG - Kirghizistan 4
KW - Kuwait 4
SN - Senegal 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AU - Australia 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
PT - Portogallo 3
TH - Thailandia 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DZ - Algeria 2
ET - Etiopia 2
GH - Ghana 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
QA - Qatar 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BW - Botswana 1
CU - Cuba 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
LU - Lussemburgo 1
MK - Macedonia 1
ML - Mali 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 14.444
Salva come PNG Salva come JPEG
Città #
Dublin 1.113
Singapore 1.080
Hong Kong 692
San Mateo 675
Dong Ket 520
Chandler 503
Santa Clara 331
Boardman 308
Medford 291
Princeton 291
Ashburn 273
Moscow 203
Altamura 193
Wilmington 180
Redmond 169
Lawrence 155
Beijing 125
Perugia 118
Ho Chi Minh City 115
Ann Arbor 96
Los Angeles 91
Saint Petersburg 91
Munich 81
São Paulo 73
New York 70
Vienna 66
Hanoi 59
Seoul 57
Norwalk 51
Helsinki 48
Tokyo 42
The Dalles 35
Andover 34
Brooklyn 33
Rio de Janeiro 32
San Paolo di Civitate 32
Montreal 30
Warsaw 29
Nuremberg 28
Timisoara 28
Kraków 27
Rome 25
Boston 24
Johannesburg 24
Stockholm 23
Chennai 22
Guangzhou 22
Belo Horizonte 21
Chicago 21
Houston 20
Shanghai 20
Denver 19
Turku 19
Atlanta 18
Dallas 18
Piscataway 18
Amsterdam 17
Den Haag 17
Phoenix 17
Brussels 16
Jacksonville 16
Orem 16
Campinas 14
Curitiba 14
Haiphong 14
London 14
Milan 14
Ottawa 14
Redwood City 14
Frankfurt am Main 13
Mexico City 13
Poplar 13
Porto Alegre 13
Brasília 12
Falkenstein 12
Manchester 12
Changsha 11
Guarulhos 11
Thái Bình 11
Tianjin 11
Charlotte 10
Goiânia 10
Mumbai 10
Quito 10
San Francisco 10
Amman 9
Fortaleza 9
Jakarta 9
Salvador 9
San Jose 9
Seattle 9
Cape Town 8
Hefei 8
Joinville 8
Lahore 8
Ankara 7
Baghdad 7
Baku 7
Bogotá 7
Caxias do Sul 7
Totale 9.282
Salva come PNG Salva come JPEG
Nome #
Beneficial effect of Crocus sativus stigma extract in amyloid-beta degradation by monocytes from sporadic Alzheimer's disease patients 130
Clinical and genetic study of an Italian family with complicated hereditary spastic paraplegia and Alzheimer's disease 114
COX inhibitors and bone: A safer impact on osteoblasts by NO-releasing NSAIDs 112
CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline: An overview in different dementia subtypes 109
ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease 108
Trans-crocetin improves amyloid-β degradation in monocytes from Alzheimer's Disease patients 104
Beta-hexosaminidase, alpha-D-mannosidase, and beta-mannosidase expression in serum from patients with carbohydrate-deficient glycoprotein syndrome type I 102
Lesser motor disability in adulthood: A ten-year follow-up of a dyskinetic patient with ADCY5 mutation 100
1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study 99
miR128 up-regulation correlates with impaired amyloid β(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease 98
Caspase 3 activation and PARP cleavage in lymphocytes from newborn babies of diabetic mothers with unbalanced glycaemic control 95
Spastic paraplegia type 4: A novel SPAST splice site donor mutation and expansion of the phenotype variability 95
Activity levels of a beta1,6 N-acetylglucosaminyltransferase in lymphomonocytes from multiple sclerosis patients 94
Clinico-genetic study of two Japanese pedigrees with hereditary spastic paraparesis and Alzheimer’s disease 94
HSP-SPG5A/CYP7B1: unusual clinical and genetic characteristics in an Indian family 92
Effects of vitamin C on fibroblasts from sporadic Alzheimer's disease patients 91
Acid glycohydrolase activities in lymphomonocyte plasma- membranes of patients with multiple sclerosis 91
a-D-Mannosidases in patients with familial Alzheimer’s disease 90
SPG11-related parkinsonism: Clinical profile, molecular imaging and l-dopa response 87
A clinico-genetical study in a large cohort of patients with spastic paraplegia type 4 (SPG4) 86
Nano- from nature to nurture: A comprehensive review on facets, trends, perspectives and sustainability of nanotechnology in the food sector 84
Recurrent de novo missense variant E210K in UBTF causes juvenile dystonia-parkinsonism 83
Transmission Jeopardy of Adenomatosis Polyposis Coli and Methylenetetrahydrofolate Reductase in Colorectal Cancer 83
ALS phenotypes with mutations in SPG11 82
Crocus sativus L. stigma extract improves amyloid-β degradation mediated by Cathepsin B in monocytes from Alzheimer’s Disease patients 82
Spastic paraplegia type 4: a novel SPAST splice site donor mutation and expansion of the phenotype variability 82
Haploinsufficiency of KMT2B causes myoclonus-dystonia with impaired psychomotor ability 82
Hereditary spastic paraplegia and Alzheimer’s disease: clinical and genetic study of a Brazilian family 82
Association analysis between Alzheimer's disease and the Nicastrin gene polymorphisms 81
Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE 81
A novel AIFM1 missense mutation in a Japanese patient with ataxic sensory neuronopathy and hearing impairment 80
Clinical and genetic features of a large cohort of Italian SPG4 patients from the D.A.I.S.Y. collaborative network 80
Clinical and genetic research in a large Ukrainian family with autosomal recessive hereditary spastic paraplegia 79
Cathepsin D expression is decreased in Alzheimer's disease fibroblasts 78
Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis 78
Lysosomal proteases cathepsin D, B, and L are down-regulated in fibroblasts from Alzheimer’s disease patients 77
Cathepsin D expression and regulation in fibroblasts from Alzheimer’s disease patients 76
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34(+) hematopoietic stem cells of relapsing-remitting multiple sclerosis patients 75
Acanthocytosis as a predisposing factor for non-ketotic hyperglycaemia induced chorea-ballism 75
A homozygous loss-of-function mutation in DNAJA3 causes hereditary motor and sensory neuropathy with spastic paraplegia (HMSN type V) 74
Identification of ALS5/SPG11/KIAA1840 Mutations in Patients with Autosomal Recessive Form of Charcot-Marie-Tooth Disease Type 2 74
Differential regulation of lysosomal enzymes in fibroblasts from Alzheimer’s disease patients 74
Prevalence of Cardiovascular Diseases in South Asians: Scrutinizing Traditional Risk Factors and Newly Recognized Risk Factors Sarcopenia and Osteopenia/Osteoporosis 73
Alpha-D-mannosidase properties in serum of patients with amyotrophic lateral sclerosis 73
Cathepsin D expression and processing in fibroblasts from Alzheimer’s disease patients 73
Phenotype variability and allelic heterogeneity in KMT2B-Associated disease 73
Neuronal inclusion formation and axonal degeneration in mutant TFG transgenic mice 72
Clinical and molecular profile of a Japanese cohort of patients with dyskinesia 72
The Puzzle of Hereditary Spastic Paraplegia: From Epidemiology to Treatment 71
Alpha-D-mannosidase properties in serum of patients with amyotrophic lateral sclerosis 71
New pathological findings in an international cohort of hereditary spastic paraplegia 4 patients. 70
Ras differentially regulates lysosomal enzymes expression 70
A novel compound heterozygous TH mutation in a Japanese case of dopa-responsive dystonia with mild clinical course 70
Hereditary spastic paraplegia type 4 (SPG4): an international multicenter clinical and genetic study. 69
Regulation of lysosomal enzymes expression in fibroblasts from Alzheimer’s disease patients 69
Association study of the 5-HT6 receptor gene in Alzheimer’s disease 69
Active secretion of lysosomal glycohydrolases by activated human platelets “in vivo” studies on lysosomal release and molecular mechanisms regulating their secretion 69
A new SPG4/SPAST mutation in an Italian family with hereditary spastic paraplegia and Alzheimer's disease 69
Search for new genes causing dementia: targets for novel diagnostics and therapeutics 68
Clinical and genetic study of a Japanese family with complicated hereditary spastic paraplegia and Alzheimer's disease 68
Lack of association between Alzheimer's disease and the promoter region polymorphisms of the nicastrin gene 67
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 67
A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis 67
A homozygous loss-of-function mutation in DNAJA3 causes hereditary motor and sensory neuropathy with spastic paraplegia (HMSN type V) 67
Clinical-Genetic Features Influencing Disability in Spastic Paraplegia Type 4: A Cross-sectional Study by the Italian DAISY Network 67
A novel mutation in the SPG3A gene (atlastin) in hereditary spastic paraplegia 66
Constitutive expression of beta-N-acetylhexosaminidase in a microglial cell line: transcriptional modulation by lipopolysaccharide and serum factors 66
Spastic paraplegia type 4: a novel SPAST splice site donor mutation and expansion of the phenotype variability 66
Hereditary Spastic Paraplegia: An Update 66
Up-regulation of glycohydrolases in Alzheimer's Disease fibroblasts correlates with Ras activation 65
SPG11 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease 65
Characterization of human Enah gene 65
Choreoathetosis, dystonia, and myoclonus in 3 siblings with autosomal recessive spinocerebellar ataxia type 16 64
a-D-Mannosidases in fibroblasts from patients with Alzheimer’s disease 64
Therapy with drug product AZD-103 may ease Alzheimer's disease 64
Cloning of human MENA gene 64
Elevated beta-N-acetylhexosaminidase activity in focal dystonia fibroblasts 64
A homozygous mutation of VWA3B causes cerebellar ataxia with intellectual disability 63
Alpha2-macroglobulin polymorphisms in Italian sporadic and familial Alzheimer's disease 63
Genetics of Alzheimer’s disease 62
Hereditary Spastic Paraplegia Type 4 (SPG4): A Clinico-Genetic Study in a Large Cohort of Patients with Spastic Paraplegia 62
Autosomal recessive hereditary spastic paraplegia with thin corpus callosum: A novel mutation in the SPG11 gene and further evidence for genetic heterogeneity 62
Absence of association between APOA1 polymorphism and Alzheimer’s disease 62
Molecular epidemiology of dystonia in Japan 62
Association study of the 5-hydroxytryptamine(6) receptor gene in Alzheimer's disease 61
Expression and processing of cathepsin D in fibroblasts of patients with Alzheimer’s disease 61
Hereditary spastic paraplegia type 31: A novel splice site donor mutation and intra-familial phenotypic variability 61
Evaluation of swallowing in patients with hereditary spastic paraplegias 61
miR128 up-regulation correlates with impaired Amyloid-β42 degradation in monocytes of patients with sporadic Alzheimer’s disease 61
Differential regulation of lysosomal enzymes in fibroblasts from patients with Alzheimer’s disease 60
Impairment of lysosomal system in neurodegenerative diseases 60
A new SPG4 mutation in a variant form of spastic paraplegia with congenital arachnoid cysts 60
Ras differentially regulates lysosomal enzymes expression 60
Therapy with drug product AZD-103 may ease Alzheimer's disease 59
Characterization of hMENA gene 59
Apolipoprotein E 3/2 genotype is associated with early onset cognitive dysfunction in SLE 59
Cathepsin D, B and L are down-regulated in fibroblasts from Alzheimer’s disease patients 59
Hereditary spastic paraplegia type 31: a novel splice site donor mutation and intra-familial phenotypic variability 59
Cohort profile of the Japan Dystonia Consortium: Genetic diagnosis and characteristics of movement disorders in Japan 59
Spastic paraplegia type 4: A novel SPAST splice site donor mutation and expansion of the phenotype variability 58
Totale 7.509
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.547
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021668 0 0 0 0 0 21 59 17 16 14 15 526
2021/20222.168 19 406 171 20 167 18 59 662 25 53 267 301
2022/20232.592 300 489 34 70 158 128 1 89 1.238 9 54 22
2023/2024993 45 88 49 23 3 12 251 27 21 52 219 203
2024/20253.651 21 329 73 61 338 273 165 205 940 251 715 280
2025/20263.566 506 371 435 1.150 883 221 0 0 0 0 0 0
Totale 16.023